STRATEGY

Astera Bio

Concentrated, long-biased portfolio of small to mid cap biotechnology & pharmaceutical companies that exhibit cutting edge science and/or platform technology anchored by a minority of established large cap companies implementing efficient innovation to stay relevant and profitable.